Danish food ingredients giant Danisco has announced that it has commissioned new production facilities worth around DKr90m (US$10.6mm) at the Grindsted site, dedicated to the production of Natamax ™, a biological protectant used by the global food industry. For five years Danisco has been holding the rights to Natamax™, which was originally developed by Pfizer. Until now, Danisco had Natamax™ produced at a Pfizer plant in the US, but Danisco has now started up production itself. Natamax™ is produced on the basis of fermentation.